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770a Wednesday, February 19, 2014sarcomere length (SL). In this study, we used time-resolved in situ FRET to
monitor the effects of Ca2þ-occupancy, XB state, and SL on N-cTnC open-
ing in skinned cardiac muscle fibers. FRET donor (AEDANS) and acceptor
(DDPM) modified double-cysteine mutant cTnC(13C/51C)AEDANS-DDPM
was reconstituted into skinned muscle fibers to examine the N domain of
cTnC (N-cTnC) opening. To study the effect of SL on structural transitions
of cTnC, we monitored the protein structural transitions at low and high
[Ca2þ] and SL 1.8 and 2.2 mm. Mg2þ-ADP and sodium orthovanadate (Vi)
were used to examine the effects of non-cyclng strong and weak XBs,
respectively. We found that strongly bound XBs alter structural transitions
of cardiac troponin only at 2.2 mm. On the other hand, Vi blunted the SL
dependent opening of N-cTnC such that weak XBs have no effect on
N-cTnC at either [Ca2þ] or SL. In addition, distance distribution analysis
indicated that N-cTnC adopts four unique conformations associated with
the four states of thin filament regulation, and that N-cTnC conformational
equilibria are caused by cycling XBs. Based on our findings, we conclude
that the observed dependence of myosin positive feedback regulation on
SL is an important determinant of the Frank-Starling law of the heart.
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Investigations of cardiomyopathy mutations in Ca2þ regulatory proteins
troponin and tropomyosin provide crucial information about cardiac disease
mechanisms, and provide insights into functional domains in the affected
polypeptides. Hypertrophic cardiomyopathy-associated mutations TnI
R145G, located within the inhibitory peptide (Ip) of human cardiac troponin
I (hcTnI), and TnT R278C, located immediately C-terminal to the IT arm
in human cardiac troponin T (hcTnT), share remarkable features: structurally,
biochemically, and pathologically. Using bioinformatics, we find compelling
evidence that affected regions of hcTnI and hcTnT, may be related_not just
structurally_but also evolutionarily. Because alignment of TnI and TnT coin-
cides with the known structure of the IT-arm, and both Arg mutations are
located close to the C-terminal end of the IT-arm, we investigated functional
relationships between hcTnI R145G and hcTnT R278C. We hypothesized that
if the mutations affected function independently, then their effects would be
additive in a double mutant complex. We characterized Tn complexes con-
taining either mutation alone, or both mutations simultaneously, using in vitro
motility assays run with varying [Ca2þ], temperature, or HMM density. Our
most significant findings show that TnT R278C "rescued" some deleterious
effects of TnI R145G at high Ca2þ, but exacerbated the loss of function
(i.e., switching off the actomyosin interaction) at low Ca2þ. Taken together,
our results raise the likelihood that cTnI’s Ip sequence might share a common
evolutionary origin with, and thus be structurally and functionally related to,
the C-terminus of cTnT. In accord with this prediction, our experimental re-
sults suggest that the C-terminus of cTnT aids Ca2þ-regulatory function of
cTnI Ip within the troponin complex.
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A long-term goal of work in our laboratories is to understand the structural ba-
sis of myofilament function, i.e. cross-bridge dynamics (CD) and myofilament
length dependent activation (LDA) in striated muscle in heath and disease.
Moreover, in cardiac muscle LDA underlies the Frank Starling Law of the
Heart. Troponin phosphorylation, and in particular troponin-I (cTnI), has
been suggested to be a pivotal modulator of myofilament function. Here weexamined the impact of phosphorylation of distinct cTnI domains on CD and
LDA in isolated human myocardium. Site specific phosphorylation was accom-
plished by charge mutation of hcTnI phosphomimics on the PKA (S23/24D),
PKC (S42/44E; T143E), AMPK (S150D), and novel (S5/6D) sites, followed
by recombinant protein exchange into skinned non-failing human LV cardiac
muscle strips (~2mm long, and ~150um diameter. Force and ATPase activity
was measured as function of [Ca2þ] at short and long sarcomere length
(SL=2.0&2.3um). We found, LDA: hcTnI-S150D attenuated, hcTnI-S42/43E
increase, and no effect for the other sites. CD as indexed by tension cost
was: decreased for cTnI-S42/44E and hcTnI-S150D, and no effect for the other
sites. We conclude that cTnI phosphorylation at distinct sites differentially
affect cross-bridge cycling and length dependent activation in human myocar-
dium. Structural analysis employing x-ray diffraction is underway to determine
the structural basis for these phenomena. Supported by NIH HL075494,
HL62426, GM103622.
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A missense mutation, R141W, in the strong tropomyosin-binding region of
human cardiac troponin T (cTnT) is associated with dilated cardiomyopathy
(DCM). Previous studies of steady-state contractile function suggest that
DCM-related mutations in cTnT attenuate myofilament Ca2þ sensitivity.
Steady-state observations by themselves may not be sufficient enough to
provide a reliable link between different mutations and divergent cardiac phe-
notypes, especially at submaximal Ca2þ levels. It is now widely appreciated
that dynamic relationships - rather than steady-state aspects of the force-pCa
relationship - dominate in conditions under which cardiac muscle functions.
To understand the effects of the R141W mutation on cardiac contractile
dynamics, we created a mouse cTnT analog (McTnTR144W) of the human mu-
tation, R141W. McTnTR144W and the wild-type McTnT were individually re-
constituted into detergent-skinned mouse cardiac muscle fibers and dynamic
contractile features were assessed at maximal (pCa 4.3) and submaximal (pCa
5.5) activations. McTnTR144W-reconstituted fibers revealed the following.
The speed of crossbridge (XB) recruitment, b, decreased significantly at
both pCa 4.3 and pCa 5.5; however, the magnitude of decrease was 2-fold
greater at submaximal activation. The speed of XB detachment dynamics,
c, also decreased and was 1.7-fold greater at submaximal activation. How-
ever, the XB strain-mediated effects on the recruitment of other XBs (g) -
mediated by allosteric/cooperative mechanisms operating within the thin
filament - decreased to a similar extent at both Ca2þ activations. Novel find-
ings from our study will be discussed in terms of the McTnTR144W-induced
effects on the thin filament cooperativity and its associations with slower
rates of XB recruitment and detachment kinetics at physiologically relevant
Ca2þ concentrations.
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We tested our hypothesis that a-myosin heavy chain (MHC) and b-MHC
differently modulate the functional effects of protein kinase C (PKC)-medi-
ated phosphorylation of rat cardiac troponin T (RcTnT). We generated a
chimeric pseudophosphorylated RcTnT in which the threonine 204 was
replaced by glutamic acid (cTnTT204E) to mimic the PKC-mediated phos-
phorylation effect. Recombinant proteins were reconstituted into detergent-
skinned cardiac muscle fibers from normal rats expressing a-MHC or
propylthiouracil-treated rats expressing b-MHC. Steady state measurements
revealed that Ca2þ-activated maximal tension and the corresponding ATPase
activity decreased significantly by ~75% in a-MHCþcTnTT204E fibers, but
only by ~33% in b-MHCþcTnTT204E fibers. However, the myofilament
Ca2þ sensitivity (pCa50) decreased by ~50% in both a-MHCþcTnTT204E
and b-MHCþcTnTT204E fibers, suggesting that the greater decrease in
maximal tension observed in a-MHCþcTnTT204E fibers cannot be merely
attributed to the decrease in Ca2þ-mediated activation of thin filaments. Inter-
estingly, the rates of tension redevelopment (ktr), crossbridge (XB) recruit-
ment dynamics (b), XB distortion dynamics (c), and the tension cost
(ATPase rate/tension) decreased only in a-MHCþcTnTT204E fibers. Our re-
sults demonstrate that a- and b-MHC isoforms have different impact on
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observations have clinical relevance because increased activity of various
PKC isoforms and upregulation of b-MHC are observed in failing human
hearts.
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Mutations in the nebulin gene (NEB), skeletal muscle alpha-actin1 gene
(ACTA1), beta-tropomyosin 2 gene (TPM2) and alpha-tropomyosin 3 gene
(TPM3) lead to thin filament myopathies, such as nemaline myopathy (NM),
congenital fiber type disproportion (CFTD) and cap disease (CAP). A hallmark
feature of these myopathies is muscle weakness. Here, we aimed to elucidate
the effect of NEB, ACTA1, TPM2 and TPM3 mutations on thin filament length
by determining the sarcomere length-dependence of force.
Quadriceps biopsies from NM, CFTD, and CAP patients (n=18) with mutations
in the NEB, ACTA1, TPM2 or TPM3 were compared to biopsies from controls
(n=3). Using permeabilized muscle fibers, maximal active tension was deter-
mined at incremental sarcomere lengths (range 2.0-3.5 mm) to obtain the
force-sarcomere length relationship.
The maximal active tension (Fmax (in mN/mm2, mean5SD)) was signifi-
cantly lower in biopsies from severe NEB (1855), mild NEB (7655), severe
ACTA1 (54513) and severe TPM3 (95514) patients compared to biopsies of
controls (164517), whereas no significant changes in Fmax were observed in
biopsies from mild ACTA1 (139527), mild TPM2 (120158) and mild TPM3
(156513) patients. The classification of severity is based on the age of onset.
No shift in the force-sarcomere length relationship was observed in mild
ACTA1, TPM3 and TPM2 patients. Interestingly, in contrast to patients with
ACTA1, TPM2 and TPM3 mutations, fiber preparations from both mildly
and severly affected NEB patients showed a leftward shift of the force-
sarcomere length relationship (a leftward shift of the force-sarcomere length
relationship indicates shorter thin filaments).
Our data suggest that mutations in NEB result in the most pronounced changes
in thin filament length. Insights in the mechanisms underlying weakness in pa-
tients with thin filament mutations are necessary to improve specific treatment
strategies.
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The mechanisms underlying most forms of Distal Arthrogryposis (DA), a group
of congenital contracture syndromes, are unknown. Our previous functional
studies from adult individuals with DA caused by the heterozygous embryonic
myosin heavy chain mutation,MYH3 R672C, showed that the time required by
DA skinned skeletal myofibers to relax completely after calcium-induced
contraction was several-fold longer than controls (Racca et al. (2010) Biophys
J 98:542-3a). Here we measured force and kinetics of activation & relaxation,
and compared chemomechanical analysis using myofibrils and myofibers
sampled from gastrocnemius muscle from two affected individuals vs. three
control (non-DA) individuals. The prolonged relaxation was reflected in iso-
lated myofibrils from DA patients, as 50% relaxation time from maximal acti-
vation was 36% longer, and 90% relaxation time was prolonged by 58%. The
kinetics of the slow phase of relaxation were significantly slower, in both the
rate and duration (DA: kREL,SLOW=0.3650.07s
1;tREL,SLOW=285521ms vs.
Control: 0.7950.18s1;199523ms), implying slower cross-bridge release.
Use of ADP prolonged relaxation of control samples to a greater extent than
DA preparations, suggesting that slower ADP release from myosin in DA
myofibrils may be the mechanism of slower relaxation and cross-bridge release.
We also found that both mRNA and protein for this "embryonic" myosin (gene
MYH3) were present in adult skeletal muscle, such that a small amount of
this slower myosin may prolong relaxation. Although the mechanism that
leads to the congenital contractures must begin prenatally, these results suggest
that MYH3 R672H also affects ongoing function of adult skeletal muscle. Un-
derstanding the mechanism by which myosin mutations affect muscle cell
contractility could provide a model for exploring the pathogenesis of more
common contractures such as idiopathic clubfoot and facilitate the develop-
ment of novel therapeutic approaches. Supported by F31AR06300(A.R.),
5K23HD057331(A.B.), HD048895(M.B.,M.R.).3892-Pos Board B620
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In Familial Hypertrophic Cardiomyopathy (FHC) 1/3 of the patients are
affected by mutations in the ß-myosin heavy chain (ß-MyHC), the myosin iso-
form of the ventricle and of slow skeletal muscle fibers in humans. Yet, not
much is known about (i) direct effects of specific ß-MyHC-mutations on
acto-myosin function, and (ii) how these mutations may trigger development
of the FHC-phenotype.
To address these questions, we analyzed the effects of the ß-MyHC-mutation
R453C on contractile properties of slow (type I) fibers from the M. soleus of
a severely affected FHC patient. We found an about 12% higher isometric
force, 15% faster rate constant of force redevelopment (ktr), 10% higher
isometric ATPase activity and essentially unchanged tension cost. Together
with only slightly higher fiber stiffness in rigor, a main part of the increase
in isometric force appears to be due to altered cross-bridge cycling kinetics,
specifically an increase in fapp, the rate constant for the cross-bridge
transition into force generating states. Currently we investigate whether
increased force generated per myosin head e.g., by a larger y0-value also
contributes.
Relative quantification of mutated vs. wildtype ß-MyHC-mRNA of the hetero-
zygous patient revealed a fraction of about 35% for the R453C-mRNA.
Assuming similar abundance of mutated MyHC at the protein level, as we
had found in other FHC-mutations, about a third of the ß-myosin heads in
the sarcomeres carry the mutation. Thus, force contribution of the mutated
myosin head population is about 40% increased. A larger variability in pCa50
among individual fibers with mutation R453C vs. control fibers, as we had
seen for other FHC-mutations, suggests unequal expression of mutated myosin.
We hypothesize that unequal expression of mutated myosin in individual car-
diomyocytes causes imbalanced force generation and initiates functional
impairment of the myocardium in FHC.
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Familial hypertrophic cardiomyopathy (FHC) is a disease of the heart caused
by autosomal dominant mutations in genes coding for all major sarcomeric pro-
teins, including the myosin regulatory light chain (RLC). In this report, we have
explored the rescue strategies to ameliorate the malignant cardiomyopathy
phenotype induced by an aspartic acid to valine substitution (D166V) in the
RLC. Previous studies on porcine reconstituted preparations showed that the
phosphorylation mimic (S15D) in the background of the D166V mutation
(S15D-D166V) restored the calcium sensitivity of force and improved Vmax
of myosin ATPase that were largely compromised by the D166V mutation.
Transgenic "Rescue Mice" carrying the S15D-D166V mutation have been
generated and subjected to structural and functional measurements. Small angle
X-ray studies on freshly skinned papillary muscle fibers revealed that a D166V-
induced reorganization in cross-bridge mass distribution was partially reversed
in Rescue Mice (abnormally increased I1,1/I1,0 ratio observed in Tg-D166V fi-
bers returned to the value near Tg-WT). Noteworthy, pseudo-phosphorylation
of D166V significantly restored fiber elasticity allowing for changes in the
cross-bride mass distribution on stretch. In vivo cardiac morphology and func-
tion were assessed by non-invasive echocardiography followed by invasive left
ventricular pressure-volume measurements (P-V loops). Echocardiography
assessment confirmed hypertrophy in Tg-D166V mice showing an increased
posterior wall thickness in systole. Invasive hemodynamics showed diastolic
and systolic dysfunction in Tg-D166V mice. The end-systolic P-V relationship,
a measure of heart contractility, which was largely reduced in Tg-D166V mice
was completely ameliorated in Rescue Mice. In addition, the maximum dP/dt -
End-Diastolic Volume relation, which was compromised in Tg-D166V was
fully reversed in Rescue Mice. In conclusion, our results suggest that
pseudo-phosphorylation of myosin RLC can mitigate both the structural and
functional abnormalities of the FHC heart. Supported by NIH-HL108343 and
HL071778 (DSC).
